DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Korjian S, Braunwald E, Daaboul Y. et al.
Usefulness of rivaroxaban for secondary prevention of acute coronary syndrome in patients with history of congestive heart failure (from the ATLAS-ACS-2 TIMI-51 trial).
Am J Cardiol 2018;
122 (11) 1896-1901
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.